pharmacokinetics造句61. Objective:To observe the changes of fentanyl pharmacokinetics in rats during anhepatic phase by treatment of large dose of dexamethasone and to investigate the extrahepatic metabolism of fentanyl.
62. Aim:To develop a high performance liquid chromatographic (HPLC)with electrochemical detection method for the determination of scutellarin in rat plasma and to study its pharmacokinetics in rats.
63. OBJECTIVE:To study the pharmacokinetics and bioavailability of cefalexin dispersible tablet in healthy male volunteers.
64. Pharmacokinetics ( PK ) and pharmacodynamics ( PD ) are two important parts of pharmacology.
65. OBJECTIVE To establish a LC-MS/MS method for the simultaneous determination of guaifenesin, bromhexine, ambroxol in human plasma and to study their pharmacokinetics in healthy volunteers.
66. OBJECTIVE:To study the pharmacokinetics and relative bioavailability of ibuprofen sustained release capsules in healthy volunteers for evaluating the bioequi valency .
67. Conclusions Meclofenoxate, another component in the powder injection of piracetam and meclofenoxate, does not influence the pharmacokinetics of piracetam, the major component.
68. AIM : To study pharmacokinetics and bioavailability of chlorpheniramine maleate tablets in young healthy volunteers.
69. CONCLUSION The method applied for determination of gentiopicrin content in blood was simple, accurate and feasible for the study of gentiopicrin pharmacokinetics in rats.
70. Objective: To study the pharmacokinetics of cefradine capsules and establish a HPLC method for determining the contents of the cefradine in human plasma.
71. The pharmacokinetics of Isoxicam solution in rabbits and rats was investigated.
72. Objective To study the human pharmacokinetics and bioequivalence of erythromycin ethylsuccinate suspension.
73. Multidrug resistance-associated protein(MRP) plays an important role in the pharmacokinetics of a drug in the body. However, the function of MRP can be affected by probenecid.
74. To study the pharmacokinetics and relative bioavailability of tosufloxacin tosylate dispersible tablet in healthy volunteers.
75. OBJECTIVE To establish a HPLC-ECD method for determining scutellarin in rat plasma and to study pharmacokinetics of scutellarein in rats.
76. AIM: To study the pharmacokinetics and relative bioavailability of propylthiouracil tablet in Chinese healthy male volunteers.
77. AIM:To study the pharmacokinetics and bioequivalence of spironolactone in Chinese healthy people.
78. Conclusion CYP2C9 genetic polymorphism has a significant influence on the pharmacokinetics of tolbutamide. Pharmacogenomic study will be helpful in guiding rational and individualized medication.
79. Aim To investigate the effect of ketoconazole on the metabolism in vitro and pharmacokinetics of saquinavir.
80. HPLC method was established for the determination of scutellarin in rat plasma, and pharmacokinetics after ig administration of Yinshanlian granules were investigated.
81. OBJECTIVE To study pharmacokinetics and Bioequivalence of domperidone chewable tablets in healthy Chinese volunteers.
82. AIM : To compare pharmacokinetics and bioavailability of Naproxen Sodium Tablets with imported in 20 healthy male volunteers .
83. The article describes its pharmacokinetics, the mechanism of action, and clinical trials as an anti - depressant.
84. These results suggested that the multiple-peak phenomenon of PIX pharmacokinetics was caused by enterohepatic circulation (EHC).
85. Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
86. Conclusion Pharmacokinetics study on target of toxic components with cross-reaction of periplocoside is feasible through drug monitor system of digoxin immunoreaction.
87. AIM To study the pharmaceutical characterization and pharmacokinetics of long circulating liposomes containing daunorubicin.
88. OBJECTIVE:To determine the pharmacokinetics and relative bioavailablityof triprolidine hydrochloride capsules and tab1ets.
89. Methocarbamol is a useful adjunct in improving patient recovery. In this article, we summarized its pharmacokinetics, synthesis, pharmacological effect, clinical use and safety.
90. The effect of florfenicol(FFC) on the activity of cytochrome P450 2E1 in Carassius auratus was evaluated by pharmacokinetics using chlorzoxazone(CZX) as a specific substrate.